Avalyn Pharma Inc.
AVLN
$38.71
$2.135.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 352.43M | 123.13M | -- | ||
| Total Receivables | 1.67M | 253.00K | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 1.61M | 864.00K | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 2.28M | 5.74M | -- | ||
| Total Current Assets | 357.99M | 129.99M | -- | ||
|
|
|||||
| Total Current Assets | 357.99M | 129.99M | -- | ||
| Net Property, Plant & Equipment | 3.35M | 2.68M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 3.01M | 3.00M | -- | ||
| Total Assets | 425.45M | 135.66M | -- | ||
|
|
|||||
| Total Accounts Payable | 2.65M | 3.15M | -- | ||
| Total Accrued Expenses | 7.35M | 8.13M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 816.00K | 507.00K | -- | ||
| Total Finance Division Other Current Liabilities | -- | -- | -- | ||
| Total Other Current Liabilities | -- | -- | -- | ||
| Total Current Liabilities | 10.81M | 11.79M | -- | ||
|
|
|||||
| Total Current Liabilities | 10.81M | 11.79M | -- | ||
| Long-Term Debt | 14.80M | 14.81M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 1.49M | 1.09M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 27.10M | 27.69M | -- | ||
|
|
|||||
| Common Stock & APIC | 719.61M | 27.97M | -- | ||
| Retained Earnings | -321.17M | -292.23M | -- | ||
| Treasury Stock & Other | -95.00K | 12.00K | -- | ||
| Total Common Equity | 398.35M | -264.25M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 372.22M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 372.22M | -- | ||
|
|
|||||
| Total Common Equity | 398.35M | -264.25M | -- | ||
| Total Preferred Equity | -- | 372.22M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 398.35M | 107.98M | -- | ||
|
|
|||||